CPT® Code 81290

Molecular genetic testing, specifically for the MCOLN1 gene, is a diagnostic procedure aimed at identifying mutations associated with mucolipidosis, type IV. The MCOLN1 gene encodes the mucolipin 1 protein, which plays a crucial role in the transport of fats and proteins across the membranes of lysosomes and endosomes—cellular structures responsible for digesting and recycling material. When mutations occur in the MCOLN1 gene, the production of functional mucolipin 1 is compromised, leading to a lysosomal storage disorder known as mucolipidosis, type IV. This disorder is characterized by the accumulation of fats and proteins within lysosomes and endosomes, which can disrupt normal cellular function. The mucolipin 1 protein is essential for the proper development and maintenance of various cell types, including brain and nerve cells, light-sensitive retinal cells, and cells that produce digestive acids. Mucolipidosis, type IV is inherited in an autosomal recessive manner, meaning that individuals must inherit mutations from both parents to manifest the disease. Those who inherit the mutation from only one parent are considered carriers. The condition is particularly prevalent among individuals of Ashkenazi Jewish descent, with specific common variants identified in this population that lead to nonfunctional mucolipin 1 protein. Symptoms typically manifest in the first year of life and can include developmental delays, vision loss, and other serious health issues, while atypical forms may present milder symptoms later in life. Molecular genetic testing is crucial for diagnosing this disorder, especially in individuals exhibiting symptoms of lysosomal storage disorders or those with a family history of mucolipidosis, type IV.